Mirae Asset Global Investments Co., Ltd. Axogen, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 17,616 shares of AXGN stock, worth $133,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,616
Previous 18,401
4.27%
Holding current value
$133,881
Previous $125,000
13.6%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXGN
# of Institutions
126Shares Held
34.1MCall Options Held
80.7KPut Options Held
3.3K-
Arrow Mark Colorado Holdings LLC Denver, CO4.73MShares$35.9 Million0.47% of portfolio
-
Black Rock Inc. New York, NY3.23MShares$24.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.18MShares$24.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.11MShares$23.6 Million2.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$18.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $321M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...